Vivanza Biosciences Ltd Share Price – BSE

Pharmaceuticals, Small Cap

Vivanza Biosciences will hold a meeting of the Board of Directors of the Company on 18 June 2026.

Net Loss of Vivanza Biosciences reported to Rs 0.45 crore in the quarter ended March 2026 as against net loss of Rs 1.00 crore during the previous quarter ended March 2025. Sales rose 1225.00% to Rs 6.36 crore in the quarter ended March 2026 as against Rs 0.48 crore during the previous quarter ended March 2025.

For the full year,net profit reported to Rs 0.39 crore in the year ended March 2026 as against net loss of Rs 0.67 crore during the previous year ended March 2025. Sales rose 1462.13% to Rs 115.91 crore in the year ended March 2026 as against Rs 7.42 crore during the previous year ended March 2025.

Powered by Capital Market - Live News

Vivanza Biosciences will hold a meeting of the Board of Directors of the Company on 4 May 2026.

Net profit of Vivanza Biosciences rose 400.00% to Rs 0.20 crore in the quarter ended December 2025 as against Rs 0.04 crore during the previous quarter ended December 2024. Sales rose 2916.67% to Rs 45.25 crore in the quarter ended December 2025 as against Rs 1.50 crore during the previous quarter ended December 2024.

Powered by Capital Market - Live News